The following significant results were found for males and females
combined: a deficit in the standardized incidence ratio for all cancers combined; elevated standardized incidence
ratios for thyroid cancer and melanoma; and elevated excess relative risks for rectum, leukemia, lung, all cancers
combined, all except lung, and all except leukemia. For males, cancers of the colon, pancreas, and testis also
showed significantly elevated excess relative risks.